205 related articles for article (PubMed ID: 25518511)
1. [Factors influencing platelet aggregation in patients with acute coronary syndrome].
Mazurov AV; Ziuriaev IT; Khaspekova SG; Iakushkin VV; Sirotkina OV; Ruda MIa
Ter Arkh; 2014; 86(9):83-9. PubMed ID: 25518511
[TBL] [Abstract][Full Text] [Related]
2. [Platelet aggregation upon acetylsalicylic acid and clopidogrel treatment and glycoprotein IIb/IIIa content in patients with acute coronary syndrome].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Golubeva NV; Ruda MIa; Mazurov AV
Kardiologiia; 2011; 51(7):4-7. PubMed ID: 21878077
[TBL] [Abstract][Full Text] [Related]
3. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome.
Wang XQ; Shen CL; Wang BN; Huang XH; Hu ZL; Li J
Gene; 2015 Mar; 558(2):200-7. PubMed ID: 25542807
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
Arya V; Mahajan P; Saraf A; Mohanty A; Sawhney JP; Bhargava M
Int J Lab Hematol; 2015 Dec; 37(6):809-18. PubMed ID: 26264906
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
9. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
[TBL] [Abstract][Full Text] [Related]
10. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
11. Relationships of glycoproteins IIb-IIIa and Ib content with mean platelet volume and their genetic polymorphisms.
Khaspekova SG; Zyuryaev IT; Yakushkin VV; Sirotkina OV; Zaytseva NO; Ruda MY; Panteleev MA; Mazurov AV
Blood Coagul Fibrinolysis; 2014 Mar; 25(2):128-34. PubMed ID: 23941967
[TBL] [Abstract][Full Text] [Related]
12. Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
Gremmel T; Durstberger M; Eichelberger B; Koppensteiner R; Panzer S
Cardiovasc Ther; 2015 Oct; 33(5):264-9. PubMed ID: 26014752
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers.
Majluf-Cruz A; Chavez-Ochoa AR; Majluf-Cruz K; Coria-Ramirez E; Pineda Del Aguila I; Treviño-Perez S; Matías-Aguilar L; López-Armenta JC; Corona de la Peña N
Platelets; 2006 Mar; 17(2):105-7. PubMed ID: 16421012
[TBL] [Abstract][Full Text] [Related]
14. The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients.
Tang N; Yin S; Sun Z; Xu X; Qin J
Scand J Clin Lab Invest; 2015 May; 75(3):223-9. PubMed ID: 25594796
[TBL] [Abstract][Full Text] [Related]
15. Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS; Jeong YH; Park Y; Park KS; Yun SE; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
JACC Cardiovasc Interv; 2011 Apr; 4(4):381-91. PubMed ID: 21511217
[TBL] [Abstract][Full Text] [Related]
16. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
[TBL] [Abstract][Full Text] [Related]
17. ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy.
Luchessi AD; Concheiro M; Germano JF; Silbiger VN; Bortolin RH; Cruz A; Quintela O; Brion M; Carracedo A; Iñiguez A; Bravo M; López-Rivadulla M; Hirata RD; Sousa AG; Hirata MH
Basic Clin Pharmacol Toxicol; 2017 May; 120(5):466-474. PubMed ID: 27862978
[TBL] [Abstract][Full Text] [Related]
18. CYP2C19 polymorphisms in acute coronary syndrome patients undergoing clopidogrel therapy in Zhengzhou population.
Guo YM; Zhao ZC; Zhang L; Li HZ; Li Z; Sun HL
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323099
[TBL] [Abstract][Full Text] [Related]
19. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A.
Klinkhardt U; Kirchmaier CM; Westrup D; Graff J; Mahnel R; Breddin HK; Harder S
Clin Pharmacol Ther; 2000 Mar; 67(3):305-13. PubMed ID: 10741635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]